We are pleased to announce that Professor Mat Upton, Chief Scientific Officer at Amprologix, will represent the company at the upcoming LSX World Congress in Boston, MA, USA.
The annual LSX World Congress brings together global leaders across the biotech, medtech, and pharmatech industries to showcase the latest innovations and shape the future of healthcare technology. Attendance at this event offers Amprologix an excellent opportunity to stay at the forefront of industry developments, expand our professional network, and engage with potential partners and investors.
Building on the success of previous LSX events, we are excited to strengthen existing relationships and forge new collaborations that support our mission of advancing the development of antimicrobials in our development pipeline.
Throughout the congress, Mat will participate in a range of activities, including sessions focused on partnerships with pharma, speed networking, and investor meetings, all designed to forge new connections and explore productive opportunities for growth.
LSX events have consistently delivered valuable outcomes for Amprologix, and we look forward to continuing this momentum at this year’s congress.
For further information on this year's LSX congress visit the event website.
